Kyle Rose
Stock Analyst at Canaccord Genuity
(2.65)
# 2,198
Out of 5,031 analysts
114
Total ratings
53.26%
Success rate
13.73%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $36.34 | -25.70% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $318.59 | +1.70% | 16 | Feb 21, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $374.42 | +16.18% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $59.58 | +19.17% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $31.42 | +125.97% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $15.31 | +43.70% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.43 | +599.30% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $14.89 | +47.75% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $66.60 | +125.23% | 17 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $5.86 | +4,507.51% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $14.74 | +83.18% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.53 | +880.39% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $16.59 | -9.58% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $153.60 | -20.57% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $4.04 | -0.99% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.66 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $101.92 | +22.65% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $36.34
Upside: -25.70%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $318.59
Upside: +1.70%
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $374.42
Upside: +16.18%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $59.58
Upside: +19.17%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $31.42
Upside: +125.97%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $15.31
Upside: +43.70%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.43
Upside: +599.30%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $14.89
Upside: +47.75%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $66.60
Upside: +125.23%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $5.86
Upside: +4,507.51%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $14.74
Upside: +83.18%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.53
Upside: +880.39%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $16.59
Upside: -9.58%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $153.60
Upside: -20.57%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $4.04
Upside: -0.99%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.66
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $101.92
Upside: +22.65%